反応式
Cl[C:2]1[C:7]2[C:8]3[CH2:14][CH2:13][CH2:12][N:11](C(OC(C)(C)C)=O)[CH2:10][C:9]=3[S:22][C:6]=2[N:5]=[CH:4][N:3]=1.[Cl:23][C:24]1[CH:25]=[C:26]([CH:28]=[CH:29][C:30]=1[F:31])[NH2:27]>>[Cl:23][C:24]1[CH:25]=[C:26]([NH:27][C:2]2[C:7]3[C:8]4[CH2:14][CH2:13][CH2:12][NH:11][CH2:10][C:9]=4[S:22][C:6]=3[N:5]=[CH:4][N:3]=2)[CH:28]=[CH:29][C:30]=1[F:31]参加物
3
実験手順
The title compound was synthesized in analogy to Example 12A from tert-butyl 4-chloro-5,6,7,9-tetrahydro-8H-pyrimido[5′,4′:4,5]thieno[2,3-c]azepine-8-carboxylate from Example 80A (349 mg, 0.40 mmol) and 3-chloro-4-fluoroaniline (61 mg, 0.42 mmol) to yield 169 mg (68% purity, 82% yield), which was used without further purification.
後処理
- customto yield 169 mg (68% purity, 82% yield), which
- customwas used without further purification
出典と根拠
- ORDレコード
- ord-45612046ffcc475b80dfbb461b510955
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08524722B2
関連ノート
読み込み中…